Alibaba Group Holding’s research arm, Damo Academy, has secured a key endorsement from the US Food and Drug Administration (FDA) for an artificial intelligence (AI)-powered cancer detection tool, as Chinese technology giants look to play a larger role in the global healthcare industry.
The FDA granted the “breakthrough device” designation to the research group’s Damo Panda model, allowing for an expedited review and approval process, Alibaba said in a statement on Thursday. Alibaba…
Article Source
https://www.scmp.com/tech/big-tech/article/3307083/alibabas-ai-cancer-detection-tool-clears-fda-hurdle-faster-approval-process
